Cargando…
Treatment of Hypertensive Heart Disease by Targeting Smad3 Signaling in Mice
Transforming growth factor β (TGF-β)/Smad3 signaling plays a central role in chronic heart disease. Here, we report that targeting Smad3 with a Smad3 inhibitor SIS3 in an established mouse model of hypertension significantly improved cardiac dysfunctions by preserving the left ventricle (LV) ejectio...
Autores principales: | Meng, Jinxiu, Qin, Yuyan, Chen, Junzhe, Wei, Lihua, Huang, Xiao-ru, Yu, Xiyong, Lan, Hui-yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475647/ https://www.ncbi.nlm.nih.gov/pubmed/32953930 http://dx.doi.org/10.1016/j.omtm.2020.08.003 |
Ejemplares similares
-
Smad7 protects against chronic aristolochic acid nephropathy in mice
por: Dai, Xiao-Yu, et al.
Publicado: (2015) -
Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin
por: Meng, Xiao-ming, et al.
Publicado: (2015) -
TGF-β/Smad signaling in renal fibrosis
por: Meng, Xiao-Ming, et al.
Publicado: (2015) -
SARS-CoV-2 N protein induces acute kidney injury in diabetic mice via the Smad3-Ripk3/MLKL necroptosis pathway
por: Liang, Liying, et al.
Publicado: (2023) -
Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In Vitro
por: Tang, Li-xia, et al.
Publicado: (2012)